(Q50876217)
Statements
Nivolumab in patients with metastatic DNA mismatch repair-deficient or microsatellite instability-high colorectal cancer (CheckMate 142): an open-label, multicentre, phase 2 study (English)
Michael J Overman
Ray McDermott
Joseph L Leach
Michael A Morse
Andrew Hill
Michael Axelson
Rebecca A Moss
Monica V Goldberg
Z Alexander Cao
Jean-Marie Ledeine
Gregory A Maglinte
19 July 2017
1 reference